Usmle Step 2 Ck Review ~ Cardiovascular

Total Page:16

File Type:pdf, Size:1020Kb

Usmle Step 2 Ck Review ~ Cardiovascular USMLE STEP 2 CK REVIEW ~ CARDIOVASCULAR ISCHEMIC HEART DISEASE . Coronary Artery Disease (CAD) o Accumulation of atheromatous plaques within walls of coronary arteries that supply O2 to myocardium . Blood flow causes ischemia of myocardial cells due to lack of oxygen Effects of ischemia reversible if blood flow to heart improved . Complete occlusion of artery causes irreversible cell death called myocardial infarction o Risk Factors: . DM, HTN, tobacco, age >45, hyperlipidemia, LDL, HDL, homocysteine . FHx of premature CAD or MI in 1st-degree relative – men <45yrs & women <55yrs o Clinical Presentation Asymptomatic, stable angina, unstable angina, MI, sudden cardiac death o Canadian Cardiovascular Society (CCS) Angina Classification: . Class I Angina w/strenuous or rapid activity – no angina from ordinary physical activity . Class II Slight limitation of ordinary activity – angina after >2 blocks or >1 flight of stairs . Class III Marked limitation of ordinary activity – angina after <2 blocks or <1 flight of stairs . Class IV Any physical activity causes discomfort – angina may be present at rest o Diagnosis: . Resting ECG: Prior MI Q waves UA ST segment or T-wave abnormalities seen during episode of chest pain . Stress ECG: Recording ECG before, during & after exercise on treadmill 75% sensitive only if able to exercise sufficiently to reach 85% of predicted maximum HR o Predicted maximum HR = 220 − Patient’s age Should undergo cardiac catheterization if results from stress test Positive findings for CAD: o ST elevation Transmural infarct o ST depression Subendocardial ischemia o Failure to exercise >2mins due to symptoms o Hypotension o Ventricular arrhythmia . Stress Echocardiography: Performed before & immediately after exercise – preferred over stress ECG More sensitive in detecting ischemia, can assess LV size, EF & diagnose valvular disease Ischemia evidenced by wall motion abnormalities not seen at rest – akinesis or dyskinesis Should undergo cardiac catheterization if test results . Myocardial Perfusion Imaging (MPI): Stress test preformed after injection w/radioisotope – Thallium-201 or Technetium-99 Nuclear imaging obtained immediately after exercise & again after 4hrs Viable cells extract radioisotope from blood – no uptake means no perfusion to area MPI can assess myocardial viability by detecting perfusion, ventricular volume & EF o Reversible ischemia Impaired perfusion only during stress o Infarction Impaired perfusion at rest & during stress MPI has best sensitivity & specificity of exercise stress tests – but more expensive . Pharmacologic Stress: If unable to exercise – administer IV agents to stimulate myocardial function Dobutamine Myocardial O2 demand by HR, BP & contractility Adenosine & Dipyramidole Vasodilation actually causes flow to coronary arteries . Holter Monitoring Ambulatory ECG useful in detecting silent ischemia . Cardiac Catheterization & Coronary Angiography: Most accurate way of identifying severity of vessel involvement – indicated in following: o After positive results from any stress test o If revascularization or other surgical intervention being considered o Angina – difficulty diagnosing, refractory to medical therapy, occurring after MI o Severely symptomatic requiring urgent diagnosis & management o Evaluation of valvular disease to determine need for surgical intervention 1 o Treatment: . Risk Factor Modification: Smoking cessation – 50% reduction in CAD risk 1yr after quitting HTN control – esp. diabetics Hyperlipidemia – low-fat diet & HMG-CoA reductase inhibitors DM – strict glycemic control to reduced vascular disease risk Exercise & Weight loss – also modifies other risk factors like DM, HTN, hyperlipidemia Diet – intake of saturated fat (<7% total calories) & cholesterol (<200 mg/day) . Pharmacologic Management: Aspirin Morbidity & risk of MI – indicated in all pts. w/CAD o Clopidogrel If ASA contraindicated or in combination w/ASA β-blockers O2 demand via HR, contractility, BP o Mortality risk – shown to reduce frequency of coronary events o Cardioselective agents preferred – Metoprolol, Atenolol, Carvedilol . Avoids inhibition of peripheral vasodilation & bronchodilation via 2 Nitrates O2 demand via vasodilation – preload, afterload, coronary perfusion o Symptomatic control of angina only – no impact on survival o Tachyphylaxis – prevent tolerance by maintaining daily nitrate-free intervals CCBs O2 demand via coronary vasodilation – afterload, coronary perfusion o 2nd line when β-blockers or Nitrates not fully effective o Caution: Verapamil/Diltiazem + -blockers may cause bradycardia or AV block ACEIs Not used to treat symptomatic CAD – indicated in CHF, HTN, DM, LV dysfunction . Revascularization: Percutaneous Coronary Intervention (PCI): o PTCA indicated in moderate one- or two-vessel disease w/normal EF: . Medically refractory angina . NSTEMI/UA w/TIMI risk score ≥3 . Primary PCI for STEMI o Restenosis rates up to 40% within first 6 months – stents significantly rates Coronary Artery Bypass Grafting (CABG): o Indicated in severe multi-vessel disease w/ EF or comorbid DM: . Left main artery disease . Triple-vessel disease w/ LV function . Two-vessel disease w/proximal LAD stenosis . Failed or contraindicated PTCA Thrombolysis t-PA, Streptokinase, Urokinase, Anistreplase, Alteplase, Reteplase o Indications STEMI <12hrs after symptom onset or when PCI not viable option . Administer as soon as possible – preferably 3hrs after onset . Not indicated for NSTEMI or UA as artery not occluded o Absolute contraindications: . Active bleeding - Malignant IC neoplasm . Prior intracranial hemorrhage - Prior stroke (≤3 months) . Recent head trauma (≤3 months) - Suspected aortic dissection o Relative contraindications: . HTN – sBP >180 or dBP >110 - Current anticoagulation use . Recent major surgery (≤3wks) - Active peptic ulcer . Chronic Stable Angina o Symptom complex resulting from imbalance between oxygen supply & demand in myocardium o Often due to fixed stenosis caused by atheroma – O2 demand exceeds available blood supply . Goal of treatment to myocardial O2 demand & O2 supply o Pathophysiology: . Factors influencing supply Luminal diameter (most important), duration of diastole, Hb, SaO2 Myocardial O2 supply – atherosclerosis, vasospasm, hypoxemia, tachycardia, anemia . Factors influencing demand HR, contractility, wall stress Myocardial O2 demand – tachycardia, AS, myocardial hypertrophy, hyperthyroidism o Clinical Presentation: . Chest pain Retrosternal tightness radiating to left ( right) shoulder, arm, neck or jaw 2 Precipitated by the “3 E’s” – 1) Exertion, 2) Emotion, 3) Eating Brief duration – pain lasts <15mins w/relief after rest or nitrates . Anginal equivalents Dyspnea, diaphoresis, acute LVF, flash pulmonary edema . Levine’s sign Clutching fist over sternum when describing chest pain o Diagnosis Resting ECG – Normal o Treatment See Pharmacologic Management of CAD . Unstable Angina (UA) o Acute plaque rupture & thrombosis w/incomplete or transient vessel occlusion O . Oxygen demand unchanged – but O2 supply 2 to reduced resting coronary flow o UA defined by any of the following: . Angina at rest . New-onset angina . Accelerating pain pattern – frequency, duration, pain intensity o Diagnosis & Treatment See NSTEMI section below . Prinzmetal’s (Variant) Angina o Transient coronary vasospasm – 75% ass. w/fixed atherosclerotic lesion o Clinical Presentation Intermittent angina at rest – pain not provoked by exertion o Diagnosis: . ECG Hallmark is transient ST elevation during chest pain – represents transmural ischemia . Coronary Angiography Definitive test – shows coronary vasospasm after IV Ergonovine o Treatment Vasodilation via Nitrates & CCBs . Myocardial Infarction (MI) o Due to coronary atherosclerosis w/superimposed thrombus on ruptured plaque o Classification: . 1) Non-ST Elevation Myocardial Infarction (NSTEMI): Acute plaque rupture & thrombosis w/incomplete or transient vessel occlusion O Oxygen demand unchanged – but O2 supply 2 to reduced resting coronary flow Defined by presence of 2/3 criteria: o Symptoms of angina or ischemia o Rise & fall of serum MI markers – absent enzyme markers in UA o Ischemic ECG changes – without ST elevation or new LBBB NSTEMI & UA categorized together due to similar etiology & presentation . 2) ST Elevation Myocardial Infarction (STEMI): Acute plaque rupture & thrombosis w/total vessel occlusion causing myocardial necrosis Defined by new ischemic ECG changes + 1 or both of ischemic Sx. & cardiac enzymes o ECG ST elevation in 2 contiguous leads or new BBB – either LBBB or RBBB o Clinical Presentation: . Chest pain, dyspnea, diaphoresis, weakness, fatigue, N/V Pain similar to angina but more intense & longer duration Up to 1/3 asymptomatic – painless infarcts o Diagnosis: . ECG Markers for ischemia/infarction include: Peaked T-waves – occur very early & may be missed ST elevation – transmural injury of entire wall thickness (can be Dx. of acute infarct) ST depression – subendocardial injury involving inner half of wall Q-waves – seen later as specific evidence of necrosis (not seen w/NSTEMI) T-wave inversion – sensitive but not specific . Cardiac Enzymes Diagnostic gold standard for myocardial injury Creatine Kinase-MB (CK-MB): o CK-MB within 4-8hrs w/peak at 24hrs – returns to normal after 48-72hrs o Sensitivity & specificity >95% if measured within 24-36hrs of onset of chest pain o CK & CK-MB
Recommended publications
  • The Holiday Heart Syndrome
    2015/2016 Inês dos Santos Marques Alcohol and the heart março, 2016 Inês dos Santos Marques Alcohol and the heart Mestrado Integrado em Medicina Área: Cardiologia Tipologia: Monografia Trabalho efetuado sob a Orientação de: Doutor Manuel Belchior Campelo Trabalho organizado de acordo com as normas da revista: Revista Portuguesa de Cardiologia março, 2016 “Não sou mas hei de ser…” “E estou cada vez mais perto de ser…” Alcohol and the heart Álcool e coração Inês Marques1, Manuel Campelo1, 2 1Faculdade de Medicina da Universidade do Porto, Porto, Portugal 2Serviço de Cardiologia, Centro Hospitalar de São João, Porto, Portugal Corresponding author: Manuel Campelo, MD, PhD Mail: [email protected] Phone: +351 963 972 116 Number of words in the manuscript, excluding the table: 4932 1 Resumo Alguns dos efeitos benéficos da ingestão de álcool são já razoavelmente conhecidos. Contudo, os seus potenciais efeitos nefastos carecem ainda de avaliação mais detalhada. A caraterização desses efeitos em populações e contextos específicos é ainda escassa, particularmente em jovens adultos e em situações de consumo agudo e/ou em grandes quantidades. A síndroma do coração do fim-de-semana diz respeito ao desenvolvimento de uma arritmia cardíaca durante ou após o consumo agudo de uma grande quantidade de álcool, em indivíduo aparentemente saudável, e que normalmente reverte espontaneamente após um período de abstinência. Este trabalho pretende rever o estado da arte relativamente à síndroma do coração de fim-de-semana, nomeadamente nos jovens adultos. Foram selecionados na PubMed artigos referentes ao consumo de álcool no jovem e ao desenvolvimento de arritmias cardíacas. Nos adultos jovens observa-se uma acentuada heterogeneidade, no que respeita aos hábitos de consumo etílico.
    [Show full text]
  • Aberrant Ventricular Conduction Types and Concealed Conduction
    ABERRANT VENTRICULAR CONDUCTION TYPES AND CONCEALED CONDUCTION Others denominations: Aberrancy, ventricular aberration. Aberrant ventricular conduction definition: It is a term applied to alterations in QRS contour of supraventricular beats resulting from impulse transmition during periods of physiologic refractoriness and/or depressed conductivity. The supraventricular electrical impulse is conducted abnormally through the ventricular conducting system. This results in a wide QRS complex that may be confused with a ventricular ectopic beat. RELATIVE FREQUENCY OF EXPERIMENTAL ABERRATION1 Aberrant ventricular conduction was induced in 44 subjects by introduction of atrial premature beats through a transvenous catheter-electrode. Multiple patterns of aberrant ventricular conduction were obtained in 32 patients and, in the whole group, 116 different configurations were recorded. Of these, 104 showed a classical pattern of mono- or biventricular conduction disturbance. Right Bundle Branch Block (RBBB) 24%, RBBB combined with Left Anterior Fascicular Block (LAFB) 18%, LAFB 15%, RBBB combined with Left Posterior Fascicular Block (LPFB) 10%, LPFB 9%, LBBB 5%, Incomplete LBBB (ILBBB) 6%, trivial changes of the QRS contour 6% and marked anterior displacement or Prominent Anterior Forces( LSFB) 4%. Totals: RBBB: 52, LAFB: 33, LPFB: 19, LBBB: 14, trivial modifications of the QRS contour in 7 of them. In the other 5 instances, aberrant conduction manifested itself by a conspicuous anterior displacement of the QRS loop (Prominent Anterior Forces = PAF), with increased duration of anterior forces. The latter observation is worthy of notice, as it indicates that, in the differential diagnosis of the VCG pattern characterized by, conduction disturbances should be considered a possible etiological factor in addition to right ventricular hypertrophy, and true posterior wall myocardial infarction (or lateral MI in the new Bayes de Luna nomenclature concept).
    [Show full text]
  • Atrial Fibrillation
    Cardiology Research and Practice Atrial Fibrillation Guest Editors: Natig Gassonov, Evren Caglayan, Firat Duru, and Fikret Er Atrial Fibrillation Cardiology Research and Practice Atrial Fibrillation Guest Editors: Natig Gassonov, Evren Caglayan, Firat Duru, and Fikret Er Copyright © 2013 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “Cardiology Research and Practice.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Atul Aggarwal, USA H. A. Katus, Germany J. D. Parker, Canada Jesus´ M. Almendral, Spain Hosen Kiat, Australia Fausto J. Pinto, Portugal Peter Backx, Canada Anne A. Knowlton, USA Bertram Pitt, UK J Brugada, Spain GavinW.Lambert,Australia Robert Edmund Roberts, Canada Ramon Brugada, Canada Chim Choy Lang, UK Terrence D. Ruddy, Canada Hans R. Brunner, Switzerland F. H H Leenen, Canada Frank T. Ruschitzka, Switzerland Vicky A. Cameron, New Zealand Seppo Lehto, Finland Christian Seiler, Switzerland David J. Chambers, UK John C. Longhurst, USA Sidney G. Shaw, Switzerland Robert Chen, Taiwan Lars S. Maier, Germany Pawan K. Singal, Canada Mariantonietta Cicoira, Italy Olivia Manfrini, Italy Felix C. Tanner, Switzerland Antonio Colombo, Italy Gerald Maurer, Austria Hendrik T. Tevaearai, Switzerland Omar H. Dabbous, USA G. A. Mensah, USA G. Thiene, Italy Naranjan S. Dhalla, Canada Robert M. Mentzer, USA H. O. Ventura, USA Firat Duru, Switzerland Piera Angelica Merlini, Italy Stephan von Haehling, Germany Vladim´ır Dzavˇ ´ık, Canada Marco Metra, Italy James T. Willerson, USA Gerasimos Filippatos, Greece Veselin Mitrovic, Germany Michael S.
    [Show full text]
  • ECG Interpretations in Anesthesiology Topics Components of The
    ECG Interpretations for the ECG Interpretations in Anesthesia Professional Anesthesiology • ECG skills are valuable at every phase of Brian C. Weiford M.D., FACC the continuum of care Postgraduate Symposium on – Preoperative: PAT clinic, etc Anesthesiology – Intraoperative April 11, 2014 – Postoperative Topics Components of the ECG - Review P – Wave: Atrial Depolarization. • The normal ECG • Can be positive, biphasic, negative. QRS Complex: Ventricular Depolarization. • Arrhythmias • Q – Wave: 1st negative deflection wave before R-Wave. – Ectopy • R – Wave: The positive deflection wave. st – Supraventricular • S – Wave: 1 negative deflection wave after R – wave. T – Wave: Ventricular Repolarization. – Ventricular • Can be positive, biphasic, negative. • Coronary Ischemia, Injury, and Infarct • Pacemakers • Miscellaneous fun with ECGs Normal Sinus Rhythm with Normal ECG Normal variant Juvenile T wave pattern From Braunwald’s Heart Disease, 7th Ed. Sinus Arrhythmia/Dysrhythmia Sinus Bradycardia •Sinus rate < 60 bpm, but usually not clinically significant unless < 50 bpm •Sinus rate is usually > 40 bpm in normal subjects Two forms of Sinus Dysrhythmia: •HR < 40 bpm can be seen commonly in normal subjects during sleep 1) more commonly, due to respiratory variability and changes in and in well-trained athletes vagal tone •Sinus rate affected by numerous medications •Beta blockers, calcium channel blockers, digoxin, antiarrhythmics, clonidine, neostigmine, etc. 2) In elderly subjects with heart disease, and probably related to •For sinus rates
    [Show full text]
  • EKG Zmeny Pri Akútnej Intoxikácii Alkoholom
    Přehledný referát EKG zmeny pri akútnej intoxikácii alkoholom K. Trejbal, P. Mitro III. interná klinika Lekárskej fakulty UPJŠ a FN L. Pasteura Košice, Slovenská republika, prednosta doc. MUDr. Peter Mitro, Ph.D. Súhrn: U pacientov s akútnou intoxikáciou etylalkoholom sú často prítomné patologické zmeny elektrokardiogramu (EKG). Časte- jšie a prognosticky závažnejšie bývajú u chronických alkoholikov, pacientov s ischemickou chorobou srdca (ICHS), alkoholovou kardiomyopatiou, alebo iným organickým ochorením srdca, môžu sa však vyskytovať aj u mladých a zdravých jedincov. Typické EKG zmeny pri ebriete sú poruchy srdcového rytmu, a to jednak charakteru porúch tvorby vzruchu, tak aj patologického vedenia vzruchu. U ľudí bez klinického dôkazu srdcového ochorenia ich zaraďujeme pod tzv. „holiday heart syndrome“. Najčastejšia tachyarytmia je fibrilácia predsiení, zriedkavejšia, ale prognosticky podstatne závažnejšia, je polymorfná komorová tachykardia typu torsades de pointes (TdP). Z bradyarytmií je najvýznamnejšia alkoholom indukovaná sínusová bradykardia, ktorá sa môže prejaviť opakovanými synkopami. So stúpajúcou hladinou alkoholu v krvi sa zvyšuje výskyt signifikantného predĺženia jednotlivých EKG intervalov, s mož- nou manifestáciou latentnej prevodovej poruchy, či dokonca náhlej srdcovej smrti. V EKG obraze sa okrem porúch rytmu veľmi často zistia nešpecifické zmeny repolarizácie. U pacientov s ICHS dochádza pri alkoholovej intoxikácii k prehĺbeniu ischémie, ktorá prebie- ha väčšinou asymptomaticky ako tichá ischémia myokardu. Výsledný EKG obraz môžu výrazne ovplyvniť stavy, ktoré sa neraz vysky- tujú súčasne s opitosťou, ako napr. hypotermia, hypoglykémia či elektrolytová dysbalancia. Podobné EKG zmeny ako pri akútnej alkoholovej intoxikácii, vznikajú aj pri akútnom abstinenčnom syndróme, najmä pri delíriu tremens. Existujú presvedčivé dôkazy o tom, že nielen chronický alkoholizmus, ale aj nárazové pitie je spojené so zvýšením kardiovaskulárnej mortality.
    [Show full text]
  • Variance in Clinical Profile and Use of Anticoagulants in Valvular and Non Valvular Atrial Fibrillation
    World Journal of Cardiovascular Diseases, 2020, 10, 488-499 https://www.scirp.org/journal/wjcd ISSN Online: 2164-5337 ISSN Print: 2164-5329 Variance in Clinical Profile and Use of Anticoagulants in Valvular and Non Valvular Atrial Fibrillation Smriti Shakya*, Arun Sayami, Ratna Mani Gajurel, Chandra Mani Poudel, Hemant Shrestha, Surya Devkota, Sanjeev Thapa, Rajaram Khanal Department of Cardiology, Manmohan Cardiothoracic Vascular and Transplant Centre (MCVTC), Institute of Medicine, TUTH, Kathmandu, Nepal How to cite this paper: Shakya, S., Sayami, Abstract A., Gajurel, R.M., Poudel, C.M., Shrestha, H., Devkota, S., Thapa, S. and Khanal, R. (2020) Introduction: Atrial fibrillation is the most common cardiac arrhythmia en- Variance in Clinical Profile and Use of An- countered in clinical practice that affects morbidity and mortality to a large ticoagulants in Valvular and Non Valvular extent. This study was intended to determine various clinical profile and eti- Atrial Fibrillation. World Journal of Cardi- ological factors in valvular and non-valvular atrial fibrillation and evaluate ovascular Diseases, 10, 488-499. https://doi.org/10.4236/wjcd.2020.107049 the usage of anticoagulants in them in the settings of developing nation like ours. Methods: A hospital based cross-sectional observational prospective Received: June 29, 2020 study was conducted at Manmohan Cardiothoracic Vascular and Transplant Accepted: July 24, 2020 Center, Institute of Medicine, Nepal for a period of sixteen months. All the Published: July 27, 2020 patients with atrial fibrillation who were admitted in the cardiology depart- Copyright © 2020 by author(s) and ment were included. The demographic profile, etiology, clinical features and Scientific Research Publishing Inc.
    [Show full text]
  • Holiday Heart Syndrome Revisited After 34 Years
    FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA TRABALHO FINAL DO 6º ANO MÉDICO COM VISTA À ATRIBUIÇÃO DO GRAU DE MESTRE NO ÂMBITO DO CICLO DE ESTUDOS DE MESTRADO INTEGRADO EM MEDICINA DAVID MANUEL MARQUES PINTO TONELO HOLIDAY HEART SYNDROME REVISITED AFTER 34 YEARS ARTIGO DE REVISÃO ÁREA CIENTÍFICA DE CARDIOLOGIA TRABALHO REALIZADO SOB A ORIENTAÇÃO DE: RUI ANDRÉ QUADROS BEBIANO DA PROVIDÊNCIA E COSTA SETEMBRO 2012 Holiday Heart Syndrome revisited after 34 years David Tonelo BSc*, Rui Providência MD MSc, Lino Gonçalves MD PhD FESC Faculty of Medicine, University of Coimbra, Portugal Abstract Cardiovascular effects of ethanol have been known for a long time. However most research has focused on beneficial effects (the “French--Paradox”) when consumed moderately or its harmful consequences, such as dilated cardiomyopathy, when heavily consumed for a long time. An association between acute alcohol ingestion and onset of cardiac arrhythmias was first reported in early 70’s. In 1978 Phill Ettinger described for the first time “Holiday Heart Syndrome” as the occurrence, in healthy people without heart disease known to cause arrhythmia, of an acute cardiac rhythm disturbance, most frequently atrial fibrillation, after binge drinking. This name derived from the fact episodes were initially observed more frequently after weekends or public holidays. Thirty-four years have passed since original description of “Holiday Heart Syndrome”, with new research in this field, increasing the knowledge about this entity. Throughout this paper the authors will comprehensively review most of the available data concerning the “Holiday Heart Syndrome” and highlight the currently unsolved questions. Keywords: Holiday Heart Syndrome; Alcohol; Cardiac arrhythmia *Corresponding author: Tel: +351 918820405; E-mail address: [email protected] (D.Tonelo) 22 Introduction Alcohol is one of the oldest known drugs and it’s the most used recreational drug in the United States of America1 and probably in the rest of the globe.
    [Show full text]
  • Understanding This Complex Condition Part 2 - Management, Miscellaneous Causes, and Pitfalls
    UC Irvine Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health Title Wide Complex Tachycardias: Understanding this Complex Condition Part 2 - Management, Miscellaneous Causes, and Pitfalls Permalink https://escholarship.org/uc/item/7n5688sq Journal Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 9(2) ISSN 1936-900X Author Garmel, Gus M Publication Date 2008 Peer reviewed eScholarship.org Powered by the California Digital Library University of California REVIEW Wide Complex Tachycardias: Understanding this Complex Condition Part 2 - Management, Miscellaneous Causes, and Pitfalls Gus M. Garmel, MD Stanford University School of Medicine / Kaiser Permanente, Santa Clara Supervising Section Editors: Sean O. Henderson, MD Submission history: Submitted August 18, 2007; Revision Received October 19, 2007; Accepted November 26, 2007. Reprints available through open access at www.westjem.org [WestJEM. 2008;9:97-103.] INTRODUCTION to “diagnose” the ECG as “wide complex tachycardia of Patients who present with electrocardiograms (ECGs) unknown (or uncertain) etiology.” This may allow the demonstrating wide complex tachycardias (WCTs) are often treating clinician to focus on the patient and his or her challenging to clinicians. Not only may the patient present hemodynamic status, rather than the academic exercise of with (or be at risk for) hemodynamic compromise, but their ECG interpretation. The most important aspect of treating treatment may result in hemodynamic collapse if the incorrect patients who present with WCTs is to select a therapeutic pharmacologic agent is selected. In Part 1 of this article,1 approach that does no harm. Several diagnostic algorithms the identification, epidemiology, and electrophysiology of were provided for the interpretation of WCTs, although none WCTs were discussed.
    [Show full text]
  • Day 9: Rhythms: Cardiac Arrhythmias
    1. 2. 1. 1. Sinus rhythm @ ~90 bpm (arrows) 2. Junctional escape rhythm (50 bpm) with LBBB 3. Complete AV dissociation (due to 3rd degree AV block) 2. 1. Sinus rhythm 80 bpm) 2. Type II (Mobitz) 2nd degree AV block with 3:2 and 2:1 conduction 3. RBBB V1 3. 4. II V1 * * 3. 1. Sinus rhythm @ 75 bpm (arrows); 2 sinus captures (*) with RBBB aberration 2. Accelerated junctional rhythm @ 80 bpm 3. Incomplete AV dissociation due to the faster junctional rhythm; note: there is no AV block; the sinus captures whenever there is an opportunity for conduction. * * * 4. II Sinus rhythm with nonconducted PAC’s (*) in a pattern of bigeminy 5. V1 6. * * * 5. V1 1. Normal sinus rhythm (PR=220ms, QRS=120 ms) 2. Late (i.e., end-diastolic) PVC’s (*) of LV origin rsR’ 6. 1. Atrial fibrillation with one aberrantly conducted (RBBB) beat (note long cycle-short cycle rule of aberrancy, aka Ashman phenomenon) 7. V1 8. V1 7. V1 * * 1. Sinus rhythm (~70 bpm) with 2 nonconducted PAC’s (arrows) 2. Aborted 2nd degree AV block (Type I); note the PAC’s are early and they reset the sinus timing) 3. Two junctional escapes (*) 8. V1 Atrial flutter (240 bpm) with variable conduction V1 9. 10. V1 V1 9. 2:1 3:1 1. Sinus tachycardia (105 bpm) 2. 2nd degree AV block (type II); note 2:1 and 3:1 conduction ratios 3. LBBB * * * * 10. 2:1 AVB V1 F 1. Sinus rhythm (75 bpm) 2. 2nd degree AV block (2:1 conduction) with RBBB (it’s Mobitz II because the last beat has same PR interval ) 3.
    [Show full text]
  • Consensus and Controversy in the Debate Over the Biphasic Impact of Alcohol Consumption on the Cardiovascular System
    nutrients Review Consensus and Controversy in the Debate over the Biphasic Impact of Alcohol Consumption on the Cardiovascular System 1,2 2, 3 1,2 Cristian Stătescu , Alexandra Clement *, Ionela-Lăcrămioara S, erban and Radu Sascău 1 Internal Medicine Department, “Grigore T. Popa” University of Medicine and Pharmacy, 700503 Ias, i, Romania; [email protected] (C.S.); [email protected] (R.S.) 2 Cardiology Department, Cardiovascular Diseases Institute “Prof. Dr. George I.M. Georgescu”, 700503 Ias, i, Romania 3 Physiology Department, “Grigore T. Popa” University of Medicine and Pharmacy, 700503 Ias, i, Romania; ionela.serban@umfiasi.ro * Correspondence: [email protected]; Tel.: +40-0232-211-834 Abstract: In the past few decades, research has focused on the importance of addressing modifiable risk factors as a means of lowering the risk of cardiovascular disease (CVD), which represents the worldwide leading cause of death. For quite a long time, it has been considered that ethanol intake has a biphasic impact on the cardiovascular system, mainly depending on the drinking pattern, amount of consumption, and type of alcoholic beverage. Multiple case-control studies and meta- analyses reported the existence of a “U-type” or “J-shaped” relationship between alcohol and CVD, as well as mortality, indicating that low to moderate alcohol consumption decreases the number of adverse cardiovascular events and deaths compared to abstinence, while excessive alcohol use has unquestionably deleterious effects on the circulatory system. However, beginning in the early 2000s, the cardioprotective effects of low doses of alcohol were abnegated by the results of large epidemiological studies. Therefore, this narrative review aims to reiterate the association of alcohol Citation: St˘atescu,C.; Clement, A.; use with cardiac arrhythmias, dilated cardiomyopathy, arterial hypertension, atherosclerotic vascular S, erban, I.-L.; Sasc˘au,R.
    [Show full text]
  • Ashman Phenomenon: an Often Unrecognized Entity in Daily Clinical Practice
    Acta Clin Croat 2010; 49:99-100 Letter to the Editor ASHMAN PHENOMENON: AN OFTEN UNRECOGNIZED ENTITY IN DAILY CLINICAL PRACTICE Nenad Lakušić1, Darija Mahović2and Valentina Slivnjak1 1Department of Cardiology, Hospital for Medical Rehabilitation, Krapinske Toplice; 2University Department of Neurology, Zagreb University Hospital Center, Zagreb, Croatia Dear Editor, riod when supraventricular impulse reaches the His- Purkinje system resulting in a complex with RBBB2,3. We decided to reply with this letter regarding Ashman phenomenon is principally diagnosed by a the entity that is often unrecognized in daily clinical 12-lead surface electrocardiogram (ECG). Rarely, in practice. diffi cult cases, invasive electrophysiological studies Ashman phenomenon is an aberrant ventricular will be required to establish the source of an arrhyth- conduction most frequently seen during atrial fi bril- mia whether supraventricular or ventricular4. lation. Th is phenomenon is an intraventricular con- For daily use, useful criteria to establish the diag- duction abnormality caused by a change in the heart nosis of Ashman phenomenon are those described by rate. Ashman beat is typically seen when a relatively Fisch5: 1) relatively long cycle immediately preceding long cycle is followed by a relatively short cycle1. Th e the cycle terminated by the aberrant QRS complex; 2) beat with a short cycle often has right bundle-branch RBBB-form aberrancy with normal orientation of the block (RBBB) morphology (Fig. 1a). Th is phenom- initial QRS vector, a series of wide QRS supraven- enon may cause diagnostic confusion with premature tricular beats is possible; 3) irregular coupling of aber- ventricular complexes (PVCs) (Fig. 1b), and a series rant QRS complexes; and 4) lack of fully compensa- of consecutive aberrantly conducted supraventricular tory pause.
    [Show full text]
  • Master Visual Diagnosis of ECG a Short Atlas
    Master Visual Diagnosis of ECG A Short Atlas Master Visual Diagnosis of ECG A Short Atlas (Learn ECG Through ECG) Shahzad Khan MD Ren Jiang Hua MBBS MD Cardiologist Interventional Cardiologist Wuhan University School of Medicine Wuhan University School of Medicine China China ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD New Delhi • London • Philadelphia • Panama ® Jaypee Brothers Medical Publishers (P) Ltd Headquarters Jaypee Brothers Medical Publishers (P) Ltd. 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd. Jaypee-Highlights Medical Publishers Inc. 83, Victoria Street, London City of Knowledge, Bld. 237, Clayton SW1H 0HW (UK) Panama City, Panama Phone: +44-2031708910 Phone: +507-301-0496 Fax: +02-03-0086180 Fax: +507-301-0499 Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers Ltd Jaypee Brothers Medical Publishers (P) Ltd The Bourse 17/1-B Babar Road, Block-B, Shaymali 111 South Independene Mall East Mohammadpur, Dhaka-1207 Suite 835, Philadelphia, PA 19106, USA Bangladesh Phone: +267-519-9789 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd Shorakhute, Kathmandu Nepal Phone: +00977-9841528578 Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2013, Jaypee Brothers Medical Publishers All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher. Inquiries for bulk sales may be solicited at: [email protected] This book has been published in good faith that the contents provided by the authors contained herein are original, and is intended for educational purposes only.
    [Show full text]